The Vanderbilt Clinical Oncology Research Career Development Program (VCORCDP) will train clinical oncologists in the design and implementation of all phases of clinical trial research with emphasis on translational research. The goal is to encourage and train physicians in careers of academic-oriented, clinical oncologic research. Candidates will be recruited from three existing Vanderbilt programs: (1) Adult Hematology/Oncology (second and third year fellows), General Surgery/Surgical Oncology (fourth and fifth year residents), and Pediatric Oncology (second and third year fellows). Applications will be reviewed by an Advisory Committee consisting of eight faculty members from Medical Oncology, Surgical Oncology and Pediatric Oncology. Applicants accepted will participate in a comprehensive two-year didactic lecture series which focuses on biostatistics, clinical protocol design, medical ethics, grant writing, regulatory issues and epidemiology (20 percent time commitment). Trainees will initiate a mentored patient-oriented, hypothesis driven research project, which will expose them to Vanderbilt's extensive multidisciplinary clinical research community through the Vanderbilt-Ingram Cancer Center (VICC) and account for 70 percent of a trainee's time. Twenty-four faculty members from the VICC (80 percent with peer-reviewed funding) will serve as mentors. All research projects will be reviewed and approved by the Advisory Committee. Most research projects will involve multiple mentors. Training will be at the VICC, a matrix center within Vanderbilt University Medical Center (VUMC), which includes seven research programs that trainees can select from: Signal Transduction and Cell Proliferation, Cancer Genetics and Genomics, Host Tumor Interactions, Gastrointestinal Cancer, Breast Cancer, Cancer Prevention and Experimental Therapeutics. Trainees successfully completing the two-year program of didactic lectures and patient-oriented research will be awarded a Master of Science in Clinical Investigation or a Master of Public Health degree from Vanderbilt University. Support is being requested for six training positions per year.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Physician Scientist Award (Program) (PSA) (K12)
Project #
1K12CA090625-01
Application #
6323606
Study Section
Subcommittee G - Education (NCI)
Program Officer
Lei, Ming
Project Start
2001-09-21
Project End
2006-06-30
Budget Start
2001-09-21
Budget End
2002-06-30
Support Year
1
Fiscal Year
2001
Total Cost
$288,018
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Miettinen, Teemu P; Peltier, Julien; Härtlova, Anetta et al. (2018) Thermal proteome profiling of breast cancer cells reveals proteasomal activation by CDK4/6 inhibitor palbociclib. EMBO J 37:
Martin, Donna M; Rathmell, W Kimryn; Tavazoie, Sohail F (2018) Balancing dual demands on the physician-scientist workforce. J Clin Invest 128:3204-3205
Strickland, Stephen A; Shaver, Aaron C; Byrne, Michael et al. (2018) Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemia. Leuk Res 65:67-73
Shinall, Myrick C; Wilson, Jo Ellen; Karlekar, Mohana et al. (2018) Facility Placement as a Barrier to Hospice for Older Adult Patients Discharged From a Palliative Care Unit. Am J Hosp Palliat Care :1049909118791149
Guerrero-Zotano, Angel L; Stricker, Thomas P; Formisano, Luigi et al. (2018) ER+ Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors. Clin Cancer Res 24:2517-2529
Shinall, Myrick C; Ely, E Wesley; Karlekar, Mohana et al. (2018) Psychometric Properties of the FACIT-Pal 14 Administered in an Outpatient Palliative Care Clinic. Am J Hosp Palliat Care 35:1292-1294
Iams, Wade T; Beckermann, Kathryn E; Almodovar, Karinna et al. (2018) Small cell lung cancer transformation as a mechanism of resistance to PD-1 therapy in KRAS mutant lung adenocarcinoma: A report of two cases. J Thorac Oncol :
Tadros, Joseph; Goodman, Stacey; Tkaczyk, Eric R (2018) Subcutaneous scalp nodule as the presenting symptom of systemic light-chain amyloidosis. Dermatol Pract Concept 8:184-187
Lewis Jr, James S; Shelton, Jeremy; Kuhs, Krystle Lang et al. (2018) p16 Immunohistochemistry in Oropharyngeal Squamous Cell Carcinoma Using the E6H4 Antibody Clone: A Technical Method Study for Optimal Dilution. Head Neck Pathol 12:440-447
Shinall Jr, Myrick C; Martin, Sara F; Nelson, Jill et al. (2018) Five-Year Experience of an Inpatient Palliative Care Unit at an Academic Referral Center. Am J Hosp Palliat Care 35:1057-1062

Showing the most recent 10 out of 204 publications